皮膚真菌症治療薬市場：中国

中国における皮膚真菌症治療薬の需要は、過去10年間で急速に成長しています。次の10年間で、生産と需要の両方が成長を続けると見込まれます。中国経済は、20年以上にわたって鉱工業生産、輸出入、消費者消費、設備投資の継続的な増加によって刺激されてきた非常に速い成長を維持しています。

当レポートでは、中国における皮膚真菌症治療薬市場について調査し、中国の経済動向、投資環境、業界の発展、需要と供給、業界の生産能力、業界の構造、マーケティングチャネル、および主要な市場参入企業を分析しており、過去のデータと今後の予測を提供しています。

目次

第1章 イントロダクション

• 調査範囲・調査手法
• エグゼクティブサマリー

第2章 事業環境

• 経済展望
• 主要経済指標
• 工業生産
• 人口・労働力
• 外国投資
• 外国貿易
• 金融・税法
• 銀行システム・規制
• 外国為替
• 税金・関税率・関税

第3章 皮膚真菌症治療薬業界の評価

• 皮膚真菌症治療薬業界の概要
• 市場規模
• 市場成長の促進要因
• 売上
• 主要生産者の拠点・売上
• 主要生産者の市場シェア
• 人件費
• 潜在的な参入企業
• 主要な外国投資
• 技術開発

第4章 皮膚真菌症治療薬の生産・需要

• 概要
• 皮膚真菌症治療薬の需要：地域別
• 皮膚真菌症治療薬の売上
• フルコナゾールの売上・市場シェア
• イトラコナゾールの売上・市場シェア
• テルビナフィンの売上・市場シェア
• エコナゾールの売上・市場シェア
• ミコナゾール硝酸塩の売上・市場シェア
• アンホテリシンBの売上・市場シェア
• ケトコナゾールの売上・市場シェア
• クロトリマゾールの売上・市場シェア
• カスポファンギンの売上・市場シェア
• その他の抗真菌症皮膚薬の売上・市場シェア
• 皮膚真菌症治療薬の輸出入
• 価格動向

第5章　皮膚真菌症治療薬市場の展望

• 皮膚真菌症治療薬市場の見通し：概要
• 具体的な政府規制
• 消費者支出の動向
• 北東部
• 北部
• 南東部
• 中央部
• 南西部
• 北西部
• 人口動態の動向
• ヘルスケア業界の動向
• 病院・病床

第6章 市場参入チャネル

• 中国市場参入の概要
• 中国の流通システム
• 抗消化性潰瘍薬の流通経路
• 輸送・貨物インフラストラクチャ
• 通信
• 中国の市場参入
• 中国への輸出
• 間接輸出
• 直接輸出
• ライセンス・委託製造
• 中国での組み立て
• 受託製造
• 貿易許可
• 投資
• エクイティジョイントベンチャー
• 契約によるジョイントベンチャー
• 完全外資企業

第7章　生産者のディレクトリ

• 生産者のプロファイル

LIST OF TABLES

I. INTRODUCTION

• Economic Outlook Summary

II. BUSINESS ENVIRONMENT

• Key Economic Indicators
• Industrial Output
• Population and Labor Force Trends
• Foreign Investment and Loans
• Foreign Trade

III. ANTI DERMATOMYCOSIS SKIN DRUGS INDUSTRY ASSESSMENTS

• Anti Dermatomycosis Skin Drugs Sales Volume
• Major Producer Facility Locations
• Major Anti Dermatomycosis Skin Drugs Producer Sales Volume
• Market Share of Key Producers
• Major Foreign Investments

IV. ANTI DERMATOMYCOSIS SKIN DRUGS PRODUCTION AND DEMAND

V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK

• Total Anti Peptic Ulcer Drugs Consumption
• Consumer Spending Trend
• The Structure of Per Capita Expenditure in the Northeast of China
• The Structure of Per Capita Expenditure in the North of China
• The Structure of Per Capita Expenditure in the Southeast of China
• The Structure of Per Capita Expenditure in the Central of China
• The Structure of Per Capita Expenditure in the Southwest of China
• The Structure of Per Capita Expenditure in the Northwest of China
• Demographic Trends
• Health Care Industry Trends
• Hospitals and Hospital Beds

LIST OF CHARTS

I. INTRODUCTION

• Anti Dermatomycosis Skin Drugs Sales Volume

II. BUSINESS ENVIRONMENT

• China's GDP and Growth Rate
• Industrial Output by Ownership
• China's Imports and Exports

III. ANTIFREEZE & THAWING AGENT INDUSTRY ASSESSMENTS

• Anti Dermatomycosis Skin Drugs Sales Volume

IV. ANTIFREEZE & THAWING AGENT PRODUCTION AND DEMAND

• Anti Dermatomycosis Skin Drugs Sales Volume
• Worldwide Anti Dermatomycosis Skin Drugs Demand by Region
• Fluconazole Sales Volume and Market Share
• Itraconazole Sales Volume and Market Share
• Terbinafine Sales Volume and Market Share
• Econazole Sales Volume and Market Share
• Miconazole Sales Volume and Market Share
• Amphotericin B Sales Volume and Market Share
• Ketoconazole Sales Volume and Market Share
• Clotrimazole Sales Volume and Market Share
• Caspofungin Sales Volume and Market Share
• Other Anti Dermatomycosis Skin Drugs Sales Volume and Market Share
• Anti Dermatomycosis Skin Drugs Import, Export and Net Import
• Fluconazole Import, Export and Net Import
• Itraconazole Import, Export and Net Import
• Terbinafine Import, Export and Net Import
• Econazole Import, Export and Net Import
• Miconazole Nitrate Import, Export and Net Import
• Amphotericin B Import, Export and Net Import
• Ketoconazole Import, Export and Net Import
• Clotrimazole Import, Export and Net Import
• Caspofungin Import, Export and Net Import
• Other Import, Export and Net Import

V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK

VI. MARKETING STRATEGIES

• China's Distribution Channel

China's demand for Anti Dermatomycosis Skin Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2013, 2018 and 2023) and long-term forecasts through 2028 and 2033 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

• Report Scope and Methodology
• Executive Summary

II. BUSINESS ENVIRONMENT

• Economic Outlook
• Key Economic Indicators
• Industrial Output
• Population and Labor
• Foreign Investment
• Foreign Trade
• Financial and Tax Regulations
• Banking System and Regulations
• Foreign Exchange
• Taxes, Tariff and Custom Duties

III. ANTI DERMATOMYCOSIS SKIN DRUGS INDUSTRY ASSESSMENTS

• Anti Dermatomycosis Skin Drugs Industry Structure
• Market Size
• Market Growth Driver
• Anti Dermatomycosis Skin Drugs Sales Volume
• Major Producer Facility Locations and Sales Volume
• Market Share of Key Producers
• Labor Cost
• Potential Entrants
• Major Distributors
• Major Foreign Investments
• Technology Development

IV. ANTI DERMATOMYCOSIS SKIN DRUGS PRODUCTION AND DEMAND

• Overview
• Demand of Anti Dermatomycosis Skin Drugs by Region
• Anti Dermatomycosis Skin Drugs Sales Volume
• Fluconazole Sales Volume and Market Share
• Itraconazole Sales Volume and Market Share
• Terbinafine Sales Volume and Market Share
• Econazole Sales Volume and Market Share
• Miconazole Nitrate Sales Volume and Market Share
• Amphotericin B Sales Volume and Market Share
• Ketoconazole Sales Volume and Market Share
• Clotrimazole Sales Volume and Market Share
• Caspofungin Sales Volume and Market Share
• Other Anti Dermato Mycosis Skin Drugs Sales Volume and Market Share
• Anti Dermatomycosis Skin Drugs Imports and Exports
• Pricing Trends

V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK

• Anti Dermatomycosis Skin Drugs Markets Outlook Overview Concrete Government Regulations
• Health Care Insurance Industry Overview
• Consumer Spending Trends
• Northeast
• North
• Southeast
• Central
• Southwest
• Northwest
• Demographic Trends
• Health Care Industry Trends
• Hospitals and Hospital Beds

VI. MARKET ENTRY CHANNELS

• China Market Entry Overview
• China's Distribution System
• Anti Peptic Ulcer Drugs Distribution Channels
• Transportation and Freight Infrastructure
• Communications
• China's Market Entry
• Export to China
• Indirect Export
• Direct Export
• License and Contract Manufacture
• Assembling in China
• Contract Manufacturing
• Trade Permit
• Investment
• Equity Joint Venture
• Contractual Joint Venture
• Wholly Foreign-Owned Enterprise

VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY

• Anti Dermatomycosis Skin Drugs Producer Profiles and Directory